BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36801376)

  • 1. Diuresis-matched versus standard hydration in patients undergoing percutaneous cardiovascular procedures: meta-analysis of randomized clinical trials.
    Occhipinti G; Laudani C; Spagnolo M; Greco A; Capodanno D
    Rev Esp Cardiol (Engl Ed); 2023 Oct; 76(10):759-766. PubMed ID: 36801376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RenalGuard system and conventional hydration for preventing contrast-associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis.
    Wang Y; Guo Y
    Int J Cardiol; 2021 Jun; 333():83-89. PubMed ID: 33662483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Contrast-Induced Acute Kidney Injury by Furosemide With Matched Hydration in Patients Undergoing Interventional Procedures: A Systematic Review and Meta-Analysis of Randomized Trials.
    Putzu A; Boscolo Berto M; Belletti A; Pasotti E; Cassina T; Moccetti T; Pedrazzini G
    JACC Cardiovasc Interv; 2017 Feb; 10(4):355-363. PubMed ID: 28231903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
    Bolt LJJ; Sigterman TA; Krasznai AG; Sikkink CJM; Schurink GH; Bouwman LH
    BMJ Open; 2018 Oct; 8(9):e021842. PubMed ID: 30287607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
    Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation.
    Voigtländer-Buschmann L; Schäfer S; Schmidt-Lauber C; Weimann J; Shenas M; Giraldo Cortes J; Kuta PM; Zeller T; Twerenbold R; Seiffert M; Schofer N; Schneeberger Y; Schäfer A; Schirmer J; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
    Clin Res Cardiol; 2024 Jun; 113(6):801-811. PubMed ID: 37264143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast-induced nephropathy: A meta-analysis of randomized trials.
    Shah R; Wood SJ; Khan SA; Chaudhry A; Rehan Khan M; Morsy MS
    Clin Cardiol; 2017 Dec; 40(12):1242-1246. PubMed ID: 29247527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
    Mauler-Wittwer S; Sievert H; Ioppolo AM; Mahfoud F; Carrié D; Lipiecki J; Nickenig G; Fajadet J; Eckert S; Morice MC; Garot P
    JACC Cardiovasc Interv; 2022 Aug; 15(16):1639-1648. PubMed ID: 35981838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monocentric experience of the RenalGuard® system to limit post-contrast acute kidney injury in patients at high-risk undergoing interventional coronary procedures].
    Elleuch A; Hebbo A; Steinecker M; Bouaouina MS; Alqudwa A; Ghannem M; Poulos N; Aubry P
    Ann Cardiol Angeiol (Paris); 2022 Nov; 71(5):283-289. PubMed ID: 36115720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular End-Diastolic Pressure Versus Urine Flow Rate-Guided Hydration in Preventing Contrast-Associated Acute Kidney Injury.
    Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Visconti G; Airoldi F; Signoriello G; Focaccio A
    JACC Cardiovasc Interv; 2020 Sep; 13(17):2065-2074. PubMed ID: 32912462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients.
    Giacoppo D; Gargiulo G; Buccheri S; Aruta P; Byrne RA; Cassese S; Dangas G; Kastrati A; Mehran R; Tamburino C; Capodanno D
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial.
    Arbel Y; Ben-Assa E; Halkin A; Keren G; Schwartz AL; Havakuk O; Leshem-Rubinow E; Konigstein M; Steinvil A; Abramowitz Y; Finkelstein A; Banai S
    Trials; 2014 Jul; 15():262. PubMed ID: 24986373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced diuresis with the RenalGuard system: impact on contrast induced acute kidney injury.
    Solomon R
    J Cardiol; 2014 Jan; 63(1):9-13. PubMed ID: 24239195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored Versus Standard Hydration to Prevent Acute Kidney Injury After Percutaneous Coronary Intervention: Network Meta-Analysis.
    Moroni F; Baldetti L; Kabali C; Briguori C; Maioli M; Toso A; Brilakis ES; Gurm HS; Bagur R; Azzalini L
    J Am Heart Assoc; 2021 Jul; 10(13):e021342. PubMed ID: 34169747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Donahue M; De Micco F; Focaccio A; Golia B; Signoriello G; Ciardiello C; Donnarumma E; Condorelli G
    Am Heart J; 2016 Mar; 173():67-76. PubMed ID: 26920598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
    Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
    BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis.
    Cai Q; Jing R; Zhang W; Tang Y; Li X; Liu T
    J Interv Cardiol; 2020; 2020():7292675. PubMed ID: 32116474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing contrast-induced acute kidney injury with probucol and hydration in patients with coronary heart disease: A systematic review and meta-analysis of randomized controlled trials.
    Cui X; Xie B; Wang H; Liu F; Mei L; Qin F; Zhang J; Yi X
    Medicine (Baltimore); 2023 Mar; 102(11):e33273. PubMed ID: 36930109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the RenalGuard system to prevent contrast-induced AKI: A meta-analysis.
    Mattathil S; Ghumman S; Weinerman J; Prasad A
    J Interv Cardiol; 2017 Oct; 30(5):480-487. PubMed ID: 28870002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.